Question 1

What is Immutep?

Accepted Answer

Immutep is a Company.

Question 2

How often does Immutep appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 283 articles.

Question 3

When was Immutep first tracked by Ergen?

Accepted Answer

First tracked on Apr 01, 2026.

Question 4

When was Immutep last mentioned in news?

Accepted Answer

Last active on Jul 06, 2026.

Question 5

What is Immutep's current news sentiment?

Accepted Answer

Aggregate sentiment score: -60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Immutep in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving Immutep?

Accepted Answer

Immutep Class Action Lawsuits (Apr 07, 2026, 85 articles).

Question 8

Who is Immutep most connected to?

Accepted Answer

Top relationships: Lawrence Rosen, Lawrence Rosen, Philip Kim.

Question 9

How did the "Immutep Class Action Lawsuits" event impact Immutep?

Accepted Answer

Immutep's stock price fell significantly after the discontinuation of its TACTI-004 Phase III study, leading to multiple class action lawsuits alleging securities fraud.

Question 10

How did the "Immutep securities class action lawsuit" event impact Immutep?

Accepted Answer

Immutep is the defendant in multiple securities class action lawsuits alleging fraud related to its TACTI-004 trial. The trial failure and subsequent lawsuits have devastated its stock price and damaged its reputation.

Question 11

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.